Tom Brady announced he cloned his deceased dog Lua using Colossal Biosciences' technology, highlighting his interest in biotech investments and the ethical and scientific complexities of pet cloning, which remains a challenging and imperfect science.
Tom Brady revealed his dog Junie is a clone of his late family pet Lua, created by biotech company Colossal Biosciences, which he invested in. The cloning was done using a blood sample collected before Lua's death, offering his family a chance to have a part of their beloved pet again. The companies involved aim to expand cloning services for pets and conservation efforts.
Tom Brady revealed that he cloned his late dog Lua, a pitbull mix, using blood samples through a biotech company he invested in, Colossal Biosciences, to create a new dog named Junie, expressing his love for his pets and the potential for cloning technology to help families and endangered species.
Tom Brady announced that his dog Junie is a clone of his late dog Lua, made possible through a biotech company he is invested in, Colossal Biosciences, which specializes in animal cloning and de-extinction efforts.